Jeremy Salt | Chief Executive Officer
The Vaccine Group

A veterinarian by training, after completing my PhD at The Pirbright Institute in 1993 I became Head of the International FMD Vaccine Bank and held the position for 4 years. I moved to Pfizer AH in Sandwich, England in 1997 and eventually became Director of Biologicals Research for Europe, Africa & the Middle East with Zoetis, the spin out AH company from Pfizer AH. In 2014 I joined GALVmed as head of the highly diverse R&D team spread across three continents. My last move was during the Covid-19 pandemic to become CEO at The Vaccine Group, a startup company using platform viral technology to develop vaccines for use in animals.